Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors

por Moreaux, J, Reme, T, Leonard, W, Veyrune, J-L, Requirand, G, Goldschmidt, H, Hose, D, Klein, B
Publicado 2013

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study

por Rossi, J-F, Moreaux, J, Hose, D, Requirand, G, Rose, M, Rouillé, V, Nestorov, I, Mordenti, G, Goldschmidt, H, Ythier, A, Klein, B
Publicado 2009

P843: METABOLOMIC CHARACTERIZATION OF HUMAN MULTIPLE MYELOMA CELL LINE TO STUDY TUMOR RESISTANCE TO DIFFERENT CLASSES OF THERAPEUTIC AGENTS

por Steer, A., Chemlal, D., Varlet, E., Machura, A., Kassambara, A., Alaterre, E., Requirand, G., Robert, N., Hirtz, C., De Boussac, H., Bruyer, A., Moreaux, J.
Publicado 2022

P844: CHARACTERIZATION OF MULTIPLE MYELOMA CELL LINES WITH ACQUIRED-RESISTANCE TO PROTEASOME INHIBITORS HIGHLIGHTS A LINK BETWEEN RESISTANCE AND METABOLIC DEREGULATION

por De Boussac, H., Machura, A., Steer, A., Kassambara, A., Gely, M., Chemlal, D., Gourzones, C., Requirand, G., Robert, N., Vincent, L., Herbaux, C., Bruyer, A., Moreaux, J.
Publicado 2022